| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/2008 | EP1725569B1 Prodrugs of piperazine and substituted piperidine antiviral agents |
| 01/23/2008 | EP1725232B1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 01/23/2008 | EP1682113B1 Inhibitor imaging agents |
| 01/23/2008 | EP1673467A4 Systems and methods for assessing neuronal degeneration |
| 01/23/2008 | EP1673086B1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1644339B1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 01/23/2008 | EP1636215B1 Furazanobenzimidazoles |
| 01/23/2008 | EP1633714B1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists |
| 01/23/2008 | EP1633354B1 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 01/23/2008 | EP1613180B1 Synbiotic combination |
| 01/23/2008 | EP1610787B1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from tiotropium salts for the treatment of respiratory diseases |
| 01/23/2008 | EP1601352B1 Combined use of a fibrate and orlistat for the treatment of obesity |
| 01/23/2008 | EP1599169A4 Method for increasing hair growth |
| 01/23/2008 | EP1581224B1 Tiotropium-containing medicament combinations used for inhaling |
| 01/23/2008 | EP1569934B1 Cyclopropyl compounds as ccr5 antagonists |
| 01/23/2008 | EP1567498B1 Mandelic acid derivatives |
| 01/23/2008 | EP1560832B1 Pyrimido 4,5-d pyrimidine derivatives with anticancer activity |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1551828B1 Pyrazole derivatives |
| 01/23/2008 | EP1545619B1 Solution for ungual application |
| 01/23/2008 | EP1532144B1 quinuclidine derivatives and their use |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1446117A4 Treatment of acute myeloid leukemia with indolinone compounds |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | EP1436283B1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 01/23/2008 | EP1432313B1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 01/23/2008 | EP1409479B1 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1322651B1 Bicyclic heteroaromatic compounds |
| 01/23/2008 | EP1322619B1 Isoquinolinone potassium channel inhibitors |
| 01/23/2008 | EP1311261B1 Medicaments for chemotherapeutic treatment of disease |
| 01/23/2008 | EP1284725B1 Medicament for the treatment of diseases caused by parasitic protozoa |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1272178B1 Bilirubin or biliverdin degradation fragments |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1216032B1 Oral controlled release formulations |
| 01/23/2008 | EP1206937B1 Nitroimidazole external preparations for the treatment of atopic dermatitis |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1137406B2 Transdermal patch for delivering volatile liquid drugs |
| 01/23/2008 | EP1020465B1 Stereoisomeric indole compounds, process for the preparation of the same, and use thereof |
| 01/23/2008 | EP0988039B1 Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation |
| 01/23/2008 | EP0986376B1 USE OF A FACTOR Xa INHIBITing oligosaccharide WITH A PLATELET ANTIAGGREGATING AGENT FOR TREATING ARTERIAL THROMBOSIS |
| 01/23/2008 | EP0812321B1 Prokinetic oxadiazoles |
| 01/23/2008 | CN101111599A Expression carrier used for treating bacterial infection |
| 01/23/2008 | CN101111523A Process for producing natural immunobiotic extract and uses thereof |
| 01/23/2008 | CN101111509A Novel pyrimidine nucleoside compound or its salt |
| 01/23/2008 | CN101111508A Spiroketal derivative and use thereof as diabetic medicine |
| 01/23/2008 | CN101111498A Cefcapene pivoxil methanesulfonate |
| 01/23/2008 | CN101111495A Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 01/23/2008 | CN101111494A Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 01/23/2008 | CN101111492A 吲哚衍生物 Indole derivatives |
| 01/23/2008 | CN101111491A Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 01/23/2008 | CN101111490A 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 01/23/2008 | CN101111489A Amino-pyridines as inhibitors of beta-secretase |
| 01/23/2008 | CN101111488A Novel compounds |
| 01/23/2008 | CN101111486A 抗糖尿病二环化合物 Antidiabetic bicyclic compound |
| 01/23/2008 | CN101111483A Igf-1r抑制剂 Igf-1r inhibitor |
| 01/23/2008 | CN101111480A 取代的吡啶酮衍生物 Substituted pyridone derivative |
| 01/23/2008 | CN101111479A Pyridones used as inhibitors of kinases |
| 01/23/2008 | CN101111477A Benzoyl-tetrahydropyridine as glyt-1 inhibitors |
| 01/23/2008 | CN101111475A 抗病毒化合物及方法 Antiviral compounds and methods |
| 01/23/2008 | CN101111472A Tetralin and indane derivatives and uses thereof |
| 01/23/2008 | CN101111470A Crystalline acat (acyl-coa:cholesterol o-acyltransferase) inhibitor |
| 01/23/2008 | CN101111307A Process for producing coated fine particle |
| 01/23/2008 | CN101111288A Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives |
| 01/23/2008 | CN101111269A Composition for inhibiting expression of target gene |
| 01/23/2008 | CN101111266A Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 01/23/2008 | CN101111255A Methods for treating parkinson's disease |
| 01/23/2008 | CN101111252A Process for producing polypeptide mixtures using hydrogenolysis |
| 01/23/2008 | CN101111251A Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 01/23/2008 | CN101111250A Substituted 5-phenyl pyrimidines i in therapy |
| 01/23/2008 | CN101111249A Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| 01/23/2008 | CN101111248A Treatment for cancer |
| 01/23/2008 | CN101111247A Preventive or therapeutic agent for herpesvirus-related disease |
| 01/23/2008 | CN101111246A Synthesis of aryl pyrrolidones |
| 01/23/2008 | CN101111245A Extended release formulation of levetiracetam |
| 01/23/2008 | CN101111244A Composition for promoting production of hyaluronic acid containing kaempferol and quercetin |
| 01/23/2008 | CN101111243A Classes of compounds that interact with integrins |
| 01/23/2008 | CN101111242A Tablets containing ornithine hydrochloride |
| 01/23/2008 | CN101111241A Antineoplastic preparation and the use of antineoplastic preparation |
| 01/23/2008 | CN101111240A Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperp |
| 01/23/2008 | CN101111239A Composition for body fat reduction |
| 01/23/2008 | CN101111238A Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone and 2,4,4'-trichloro-2' -hydroxydiphenyl ether |
| 01/23/2008 | CN101111237A Methods for improving drug disposition |
| 01/23/2008 | CN101111236A Prevention and treatment of thromboembolic disorders |
| 01/23/2008 | CN101111235A Methods of using and compositions comprising pde4 modulators for treatment, prevention and management airway inflammation |
| 01/23/2008 | CN101111234A Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders |
| 01/23/2008 | CN101111233A Stable oral benzimidazole compositions and process of preparation thereof |
| 01/23/2008 | CN101111232A Method for the production of a tamper-proof form of administration |
| 01/23/2008 | CN101111229A Formulations of substituted benzoxazoles |
| 01/23/2008 | CN101111228A Formulations of substituted benzoxazoles |
| 01/23/2008 | CN101111225A Drug delivery materials made by sol/gel technology |